Preparation and Characterization of Site-Specific Fatty Chain-Modified Recombinant Human Granulocyte Colony Stimulating Factor

The clinical use of recombinant human granulocyte colony-stimulating factor (rhG-CSF) is limited by its short serum half-life. In this study, a long-acting strategy for site-specific modification of rhG-CSF with 1-pentadecyl-1H-pyrrole-2,5-dione (C15 fatty chain-maleimide, C15-MAL) was studied in mi...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xu-Dong, Yu, Wei-Jia, Liu, Jia-Hui, Du, Jie, Chen, Kang-Nan, Hu, Qin-Qin, Sun, Wen-Long, Ying, Guo-Qing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Bioengineering and Biotechnology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9168434/
https://www.ncbi.nlm.nih.gov/pubmed/35677307
http://dx.doi.org/10.3389/fbioe.2022.923059

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9168434/
https://www.ncbi.nlm.nih.gov/pubmed/35677307
http://dx.doi.org/10.3389/fbioe.2022.923059

Ejemplares similares